Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Dec 23;19(12):e0312507. doi: 10.1371/journal.pone.0312507

Primipaternity in multiparas as a predominant high risk factor for preeclampsia over prolonged birth intervals: A study of 33,000 singleton pregnancies in Reunion Island

Pierre-Yves Robillard 1,2,*,#, Silvia Iacobelli 1,2,, Simon Lorrain 2,#, Francesco Bonsante 1,2,, Malik Boukerrou 2,3,, Marco Scioscia 4,, Phuong Lien Tran 3,, Gustaaf Dekker 5,#
Editor: Preenan Pillay6
PMCID: PMC11665996  PMID: 39715206

Abstract

Objectives

To evaluate the relative importance of changing paternity (“primipaternity”, direct inquiry with patients) in multiparas versus prolonged birth/pregnancy interval as risk factors for preeclampsia (PE) by a logistic regression model comparing the adjusted odds ratios of both exposures.

Design

Assessment of all consecutive singleton deliveries (from 22 weeks onwards) at South-Reunion University’s maternity (Reunion Island, Indian Ocean) over 23 years (2001–2023) using an epidemiological perinatal database on obstetrical factors (264 items in total, of which, chronic or gestational hypertension, proteinuria, HELLP syndrome).

Results

Among the 53,572 multiparous singleton pregnancies, we identified 33,312 (62%) of multiparas who gave consecutive births, allowing calculation of birth intervals.

Primipaternity multipara (N = 2790) were on average older than those in stable relationships (N = 50,782), 31 vs 30 years, p< 0.0001; they had almost systematically longer birth intervals compared with controls of approximately 1.5 year from the 2nd to the 4th pregnancy and approximately 1year after the 5th pregnancy (all p < 0.05). In the logistic regression model of 11 risk factors, intervals between pregnancies had similar adjusted odds ratios (1.05, p = 0.002) as increasing maternal age (AdjOR 1.02, p = 0.02), increasing parity (adjOR 1.09, p = 0.02) and pre-pregnancy BMI (AdjOR 1.05, p< 0.0001). Smoking was associated with an AdjOR of 0.85 (non-significant),primipaternity multiparas were twice as likely to be smokers (23.8% vs 13.4%, p< 0.0001) compared with controls. AdjOR for primipaternity was 3.34 (p < 0.0001) indicating that primipaternity as risk belonged in the category of well-established risk factors like history of preeclampsia (11.2, p< 0.0001) and chronic hypertension (6.45, p< 0.0001).

Conclusions

Primipaternities in multiparae belongs to the major risk factors such as history of preeclampsia, chronic hypertension, multiple pregnancies while prolonged birth intervals belongs to moderate “regular physiological aging processes” such as increasing maternal age, parity or increasing pre-pregnancy BMI.

Introduction

In 2002 Skjaerven et al. stated “After adjustment for the interval birth, a change of partner is not associated with an increased risk of preeclampsia” (PE) after analysis of The National Birth Registry of Norway during the period 1967–1998 (on 500,000 multiparas); paternity being probably based on a change of patronymic name of successive siblings [1]. In 2001, one year earlier, Trogstad et al [2] on the exact same population and period of study also concluded that “the impact of changing paternity on preeclampsia risk had been confounded by insufficient control for the time interval between the pregnancies”, but they also found that prolonged birth interval is not a risk factor in women with previous PE with or without new paternity.

Interestingly, Trogstadt et al. investigated the effect of prior miscarriage/abortions (< 22 week’s gestation) in nulliparous women within a Norwegian MoBa cohort [3]. This study identified that prior to abortion with the same partner a reduced risk of PE was observed however, not in women with new paternity pregnancies. These findings suggested that normal pregnancies interrupted at early gestation may induce immunological changes that reduce the risk of preeclampsia in subsequent pregnancies. Importantly, a study by Skjaerven et al.’s [1] had tremendous impact as it directly contrasted our preceding publications on the importance of ‘primipaternity’ [4,5].

In those studies we showed that in Guadeloupe (French West Indies) a change of paternity for the index pregnancy, based on direct inquiries with multiparas, was strongly associated with PE [5]. Over the past decades the relative importance of prolonged birth interval versus primipaternity has remained a controversial topic. From an etiological perspective, this ongoing scientific debate is not a trivial one; evidently, the primipaternity paradigm is in line with the fundamental concept that human placentation may be considered as a “fetal hemigraft”, and as such the classic superficial cytotrophoblast invasion of the spiral particularly in early-onset PE with fetal growth restriction could therefore represent a type of immunological maladaptation of this fetal hemigraft [69]. On the other hand, prolonged interval between pregnancies in multiparas as a direct major risk factor for PE appears to be more in line with a kind of vascular maternal problem that increases progressively with time (a kind of “aging approach”). This was also supported by Tanberg et al. (also in Norway) who concluded on a cohort of 500,000 mothers after assisted reproductive technologies (ART, period 1988 to 2009 –so with a ten year overlap of the prior Skjaerven cohort) that the PE risk may increase by parity, interbirth interval and advanced maternal age, but with not with change of father or smoking [10]. In contrast, in 2000 a study published by Li and Wi based on 140,147 women with two consecutive births (Californian birth certificate 1989–1991) [11] among women without PE/eclampsia in the 1st pregnancy, changing partners resulted in a 30% increase in the risk in the subsequent pregnancy compared with those who did not change partner (95% CI: 1.1–1.6). On the other hand, among women with PE in the 1st birth, changing partner resulted in a 30% reduction in the risk of PE in the subsequent pregnancy (95% CI: 0.4–1.2). Interbirth interval was very unlikely to be a confounder in the Li and Wi study since the authors restricted their population to births that were between 1–3 years apart [11]. Hercus and Dekker in an Australian population studied this problem in 2020 [12] and concluded that “both prolonged birth intervals and primipaternity are independent risk factors for preeclampsia in multigravidae”.

Notwithstanding the fact that we have previously discussed some concerns regarding the Skjaerven’s study [6,7,13], it is clear that the relative importance of prolonged birth interval versus primipaternity as PE risk factor in multiparous women still represents an important fundamental research question.

The aim of this study was to address this fundamental question by a comprehensive analysis of our 23year pregnancy cohort in Reunion island using a detailed high quality perinatal database where we have an item “changing paternity” by direct inquiry to the women (PE and controls).

Material and methods

In order to analyse the relative importance of changing paternity (“primipaternity”) in multiparas versus prolonged birthinterval as risk factors for PE, we used the exposures “changing paternity”, and birth interval both items captured in the database bedides the standard booking characteristics. In multiparous women, the question of possible changed paternity is directly asked to all individual patients at time of the booking visit since 2018. Risk factors for PE between multiparae with a new male partner for the index pregnancy were compared with stable couples.

From January 1st, 2001, to December 31, 2023 (23 years), the hospital records of all women who gave birth at the maternity department of the University South Reunion Island were abstracted in a standardized fashion. The study sample was drawn from the hospital perinatal database which prospectively records data of all mother-infant pairs since 2001. Information is collected at the time of delivery and at the infant hospital discharge and regularly audited by appropriately trained staff. This epidemiological perinatal data base contains information on obstetrical risk factors, description of delivery, and maternal and neonatal outcomes. For the purpose of this study, records have been validated and have been used anonymously. All pregnant women in Reunion Island as part of the French National Health Care System have their prenatal visits, biological and ultrasound examinations, at the time of the morphology scan and anthropological characteristics recorded in a maternity booklet. Access to maternity care is free of charge as provided by the French healthcare system, which combines freedom of medical practice with nationwide social security. Hospitals have European standards of care health care, in particular maternity services are based on scheduled appointments (8 prenatal visits and on average 4 ultrasounds).

Design and study population

The maternity department of Saint Pierre hospital is a tertiary care centre that performs about 4,300 deliveries per year, thus representing about 80% of deliveries of the Southern area of Reunion Island, and it is the only level-3 maternity (the other maternity is a private clinic only providing low risk maternity care, level 1). Reunion Island is a French overseas region in the Southern Indian Ocean.

Definition of exposure and outcomes. During the 23-year period all consecutive singleton pregnancies after 22 weeks gestation have been analysed. For multiparas, women who had changed the male partner for the index pregnancy (primipaternity) were considered as cases, those who did not were the controls.

Preeclampsia was defined according to the World Health Organization recommendations [14] and the International Society for the study of Hypertension in Pregnancy) relatively to the guidelines in force at the year of pregnancy. [15] as the new onset of hypertension (BP ≥140 mmHg systolic or ≥90 mm Hg diastolic) at or after 20 weeks’ gestation and substantial proteinuria (> 0.3 g/24 hours). Early onset preeclampsia was defined as preeclampsia resulting in birth < 34 week’s gestation.

Data are presented as numbers and proportions (%) for categorical variables and as mean and standard deviation (SD) for continuous ones, as appropriate. Comparisons between groups were performed using χ2-test and odds ratio (OR) with 95% confidence interval (CI) was also calculated. Paired t-test was used for parametric and the Mann-Whitney U test for non-parametric continuous variables. P-values <0.05 were considered statistically significant. Epidemiological data have been recorded and analysed with the software EPI-INFO 7.1.5 (2008, CDC Atlanta, OMS), EPIDATA 3.0. EPIDATA allowing the adaptation for WINDOWS 10 of the former EPI-INFO (MS DOS) in complete cooperation with CDC Atlanta. All calculations were made then with and EPIDATA Analysis V2.2.2.183. Denmark.

To validate the independent association of different outcomes Preeclampsia (PE), early onset PE, Late onset PE. Maternal age and other confounding factors on different sorts of SGA we realized a multiple regression logistic model. Variables associated with all kinds of PE in bivariate analysis, with a p-value below 0.1 or known to be associated with the outcome in the literature were included in the model. A stepwise backward strategy was then applied to obtain the final model. The goodness of fit was assessed using the Hosmer-Lemeshow test. A p-value below 0.05 was considered significant. All analyses were performed using MedCalc software (version 12.3.0; MedCalc Software’s, Ostend, Belgium).

We considered the following covariates as possible confounders in this analysis with the outcome Preeclampsia, EOP (early onset), LOP (late onset): maternal age by increment of 5 years of age, pre-pregnancy BMI by increment of 5 kg/m2, smoking during pregnancy, chronic hypertension,. Among multiparas: previous preeclampsia, previous SGA, previous abortion, previous miscarriage, interval between births and “primipaternity”. We included these variables and calculated the χ2 for trend (Mantel extension), the odds ratios for each exposure level compared with the first exposure level.

Ethics approval: This study was conducted in accordance with French legislation. As per new French law applicable to trials involving human subjects (Jardé Act), a specific approval of an ethics committee (comité de protection des personnes- CPP) is not required for this non-interventional study based on retrospective, anonymized data of authorized collections and written patient consent is not needed. Patients and Public involvement. The South-Reunion perinatal database (since 2001) includes 264 items. It is considered as a fully medical database, datasheets are electronically completed solely by midwives, obstetricians and neonatologists. All epidemiological studies are obligatorily performed on anonymized data (French law). As such, there is no direct patient or public involvement.

Results

During the 23-year period (January 1, 2001- December 31, 2023) there were 86,376 singleton pregnancies. Among the 53,572 multiparous singleton pregnancies, we could identify 62%v of multiparas with consecutive births (33,312/53,572) in our maternity, allowing the calculation of birth intervals.

Table 1, depicts the major maternal characteristics with in the right columns known preeclampsia risks in all our singleton multiparas, N = 53,572.

Table 1. Maternal characteristics.

Preeclampsia risks. Multiparous, 2nd pregnancy and over.

////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
Maternal characteristics = >
///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
Controls:
Multiparous with same father
N = 50,782 (%)
Multiparous with NEW father for the index pregnancy
N = 2790 (%)
OR
[95% CI]
P
value
///////////////////////////////
///////////////////////////////
///////////////////////////////
Preeclampsia
risks = >
//////////////////////////////////////////////////////////////
//////////////////////////////
Controls:
Multiparous with same father
N = 50,782 (%)
Multiparous with NEW father for the index pregnancy
N = 2790 (%)

OR
[95% CI]

P
value
Maternal age (years: mean ± sd) 30.0 ± 6.03 31.2 ± 6.5 < .0.0001 Incidence preeclampsia (%) 1049
(2.1)
186
(6.7)
3.39
{2.9–4.0
< .0.0001
Gravidity ± sd 3.7 ± 1.9 4.3 ± 2.1 < .0.0001 Incidence EOP (%)
< 34 weeks
326
(0.7)
63
(2.4)
3.7
[2.8–4.9]
< .0.0001
Parity ± sd 2.0 ± 1.5 2.3 ± 1.6 < .0.0001 Incidence LOP (%)
≥ 34 weeks
723
(1.4)
123
(4.5)
3.25
[2.7–4.0]
< .0.0001
Adolescents < 18 years 305
(0.6)
22
(0.8)
1.32
[0.9–2.0]
0.21 History of elective abortion 10,040
(19.8)
813
(29.1)
1.67
[‘1.5–1.8]
< .0.0001
Age ≥ 35 years 12,562
(24.7)
950
(34.1)
1.57
[1.45–1.7]
< .0.0001 History of miscarriage 12,143
[23.9]
764
(27.4)
1.2
[1.1–1.3]
< .0.0001
Grand multiparas (≥ 5) 6404
(12.6)
500
(17.9)
1.51
[1.4–1.7]
< .0.0001 History of previous
preeclampsia
825
(1.6)
67
(2.4)
1.5
[1.2–1.9]
< .0.0001
Education 10th grade
or over
26,606
(55.0)
1413
(51.9)
0.88
[0.82–0.95]
0.002 Previous birth of an SGA newborn 476
(0.9)
57
(2.0)
2.2
[1.7–2.9]
< .0.0001
Living single 15,009
(29.8)
1857
(66.7)
4.7
[4.4–5.1]
< .0.0001
SGA < 10th percentile 4162
(8.3)
361
[13.3]
1.7
[1.5–1.9]
< .0.0001
BMI kg/m2 (mean ± sd) 25.9 ± 6.5 25.8 ± 6.4 0.47 Low birhweight
< 2500g
2216
(4.7)
574
(9.6)
2.2
[2.0–2.4]
< .0.0001
Obesity ≥ 30 kg/m 2 11,289 /48,538
(23.3)
611/2667
(22.9)
1.33
[0.89–1.1]
0.67 Intervals between pregnancies (years)
- Mean ± SD
- Median

4.3 ± 2.8
3.7

5.9 ± 3.7
5.2
< .0.0001
< .0.0001
Smoking 6785
(13.4)
664
(23.8)
2.0
[1.85–2.2]
< .0.0001

EOP: early onset preeclampsia. LOP: late onset preeclampsia SGA: small for gestational age (< 10th percentile Reunion curve)

There were 2790 multiparas with a new father for the index pregnancy vs 50,782 stable couples. Primipaternity multiparous women were more prone to be older 31 vs 30 years, to be aged over 35 (OR 1.57), grand multipara (5 children and over, OR 1.5), to have more gravidities (4.3 vs 3.7), parities (2.3 vs 2.0), to live single (OR 4.7), to smoke during pregnancy (OR 2.0), all characteristics p< 0.0001. Overall these women were less educated (10th grade and over), OR 0.88, p = 0.002. There were no differences for mean pre-pregnancy BMIs and rate of obesities (≥ 30 kg/m2, ≈ 23%).

Concerning the PE risks and diverse outcomes, primipaternity women as compared with stable couples had a major higher risk of PE OR 3.39, with a slightly higher risk of early onset PE (EOP, delivery < 34 weeks gestation), OR 3.7 compared with late onset PE (LOP, 34 weeks onward) OR 3.25, p< 0.0001. Primipaternity multiparas had more histories of preceding PE, OR 1.5, preceding birth of an SGA baby, OR 2.2, volunteer abortions, OR 1.67, preceding miscarriages, OR 1.2, all p< 0.0001. For the current index pregnancy, primipaternity multiparas had more small for gestational age newborns (SGA, birthweight <10th percentile), OR 1.7, and low birthweight (2500g) babies, OR 2.2, p < 0.0001. New paternity multiparas had on average higher birth intervals (of ap. 1.5 years) as compared with stable couples, p< 0.0001.

Table 2 Mean intervals between pregnancies (in years) and mean maternal ages, stable couples and changing paternity Systematically, primipaternity multiparas had significant higher intervals of pregnancies as compared with stable couples whatever the ranks of pregnancies: Approximately 1.5 years for the second to the fourth pregnancy (“intervals second pregnancy” being the interval between baby 1 and 2), and ap. 1 year for pregnancies over the 5th rank. Mean maternal age at all pregnancy ranks were higher in primipaternity multiparas.

Table 2. Mean intervals between pregnancies (in years) and mean maternal ages, stable couples and changing paternity.

All women
Intervals
N = 33,812
Stable couples
Same father
Intervals
N = 31,452
Changing father
Intervals
N = 1858
Intervals
P value
Stable
& new father
All women
Mean ages
Stable couples
Same father
Mean ages
Changing father
Mean ages
Maternal ages
P value
Stable vs
new father
2nd pregnancy
Mean ± SD
3.8 ± 2.5
N = 15,981
3.7 ± 2.4
N = 15,289
5.1 ± 3.0
N = 691
< 0.0001 27.9 ± 5.7
N = 26,091
27.9 ± 5.6
N = 25,003
28.3 ± 6.2
N = 1086
0.04
3rd pregnancy
Mean ± SD
4.3 ± 2.8
N = 8493
4.2 ± 2.7
N = 7996
5.8 ± 3.1
N = 496
< 0.0001 30.6 ± 5.6
N = 14,023
30.6 ± 5.6
N = 13,268
31.5 ± 6.1
N = 754
< 0.0001
4th pregnancy
Mean ± SD
4.0 ± 2.7
N = 4117
3.9 ± 2.7
N = 3811
5.3 ± 3.1
N = 306
0.0005 32.5 ± 5.5
N = 6558
32.4 ± 5.5
N = 6108
33.4 ± 5.8
N = 450
0.0002
5th pregnancy
Mean ± SD
3.7 ± 2.5
N = 2129
3.6 ±2.5
N = 1961
4.6 ± 2.8
N = 168
0.04 33.5 ± 5.3
N = 3218
33.5 ± 5
N = 2979
34.2 ± 5.1
N = 238
0.04
6th pregnancy & over
Mean ± SD
2.9 ± 2.9
N = 2592
2.9 ± 2.1
N = 2395
3.4 ± 2.4
N = 197
0.007 35.5 ± 4.7
N = 3694
35.5 ± 4.7
N = 3424
36.0 ± 4.7
N = 262
0.09

Table 3 and Fig 1. The multiple logistic regression model includes 11 items of which the 2 obligatory items having both a regular effect on preeclampsia risk: maternal ages and maternal pre-pregnancy BMI.

Table 3. Multiple logistic model with different outcomes Preeclampsia (PE), early onset PE, Late onset PE.

Singleton multiparous N = 53,584.

Preeclampsia
EARLY ONSET PE
(< 34 weeks gestation)
LATE ONSET PE
(34 weeks gestation onward)
Coeff.
OR
95% CI P Coeff.
OR
95% CI P Coeff.
OR
95% CI P
Maternal Age (increment of 5 years age) 0.018 1.02 [1.0–1.04] 0.02 0.009 1.01 [0.98–1.04] 0.55 0.02 1.02 [1.0–1.04] 0.02
Pre-pregnancy BMI (increment of 5 kg/m2) 0.04 1.05 [0.96–1.01] < 0.0001 0.03 1.03 [1.0–1.05] 0.007 0.06 1.06 [1.04–1.07] < 0.0001
Chronic hypertension 1.86 6.45 [5.0–8.3] < 0.0001 2.2 9.1 [5.9–14] < 0.0001 1.9 6.6 [4.9–8.8] < 0.0001
New father for the index pregnancy 1.20 3.34 [2.7–4.2] < 0.0001 1.35 3.85 [2.5–5.8] < 0.0001 1.12 3.08 {2.4–4.0] < 0.0001
Parity: 1-2-3-4-5 and over 0.09 1.09 [1.02–1.17] 0.02 0.04 1.04 [0.9–1.2] 0.55 0.07 1.08 [0.99–1.16] 0.06
History previous preeclampsia 2.4 11.2 [8.8–14.2] 0.0007 2.84 17.2 [11.8–25.2] < 0.0001 2.26 9.6 [.7.7–12.1] 0.02
History of previous SGA newborn 0.38 1.47 [0.71–3.0] 0.29 0.79 2.2 [0.69–70.1] 0.17 0.19 1.2 [0.5–2.99] 0.66
History of volunteer abortion -0.13 0.88 [0.7–1.07] 0.20 -0.34 0.71 [0.5–1.8] 0.11 -0.05 0.95 [0.76–1.19] 0.66
History of miscarriage 0.02 1.02 [0.85–1.2] 0.80 -0.01 0.98 [0.7–1.4] 0.94 0.02 1.02 [0.83–1.26] 0.81
Interval between pregnancies (years) 0.05 1.05 [1.02–1.09] 0.002 0.07 1.07 [1.0–1.14] 0.03 0.03 1.03 [0.99–1.07] 0.07
Smoking during pregnancy -0.16 0.85 [0.66–1.09] 0.20 -0.005 0.99 [0.63–1.6] 0.98 -0.26 0.77 [0.6–1.03 0.08

Fig 1. Significant adjusted odds ratios of several risk factors for early (EOP) and late onset (LOP) preeclampsia.

Fig 1

It is interesting in logistic models to look first at negative coefficients (meaning a protective effect towards the outcome). Although non-significant, history of volunteer abortions had a tendency to lower the incidence of PE by 13% (coefficient -0.13) and even by 34% for EOP (early onset PE). Smoking during pregnancy also had a tendency to lower the incidence of PE by 16%, effect only due to the 26% decrease concentrated only in LOP (late onset PE), and no protection towards EOP.

The three major independent risk factors, controlling for all the other items in the model were: History of preceding PE: adjusted OR 11.2, p < 0.0001. (Adj OR 17 for EOP), Chronic hypertension: Adj OR 6.45, p < 0.0001. (Adj OR 9.1 for EOP) and primipaternity for the index pregnancy: Adj OR 3.34, p < 0.0001. (3.8 for EOP and 3.1 for LOP). Controlling for the 3 major preceding factors intervals between pregnancies belongs rather to the what we may call “regular physiological aging processes” presenting a regular smooth slope rise: maternal ages coefficient 0.018 (rise of 2% for each increase of 5 years of age), parities 1-2-3-4-5 and over, coef. 0.09 (rise of 9% for each successive pregnancy), interval between pregnancies, coef 0.05. Pre-pregnancy BMI has a coefficient of 0.04 (rise of 4% for each increasing category by 5 kg/m2), effect mainly due to LOP, Adj OR 1.06, Coef 0.06, p< 0.0001.

Fig 1 visualizes all the significant adjusted odds ratios with two 2 kinds of risks: those with a low-value (Ajusted OR < 1.1): maternal ages, successive parities, pre-pregnancy BMI and intervals between pregnancies.and the ranking of major risks: history of preeclampsia Adj OR 11, Chronic hypertension AdjOR 6.45 and new paternity Adj OR 3.34.

Discussion

The results of this large population study with detailed records on the relevant variables clearly demonstrates the presence of two kinds of significant risk factors (Fig 1): Major risk factors: history of PE, chronic hypertension and primipaternity with positive coefficients of respectively 2.4, 1.9 and 1.2. (a risk rise of 24%, 19% and 12% when these risks exist) and significant risk factors with a modest incremental (low coefficients) effect with positive coefficients around 0.018 (maternal ages), 0.09 (successive parities), 0.04 (pre-pregnancy BMIs) and 0.05 (intervals between pregnancies).

Primipaternity multiparous women are in average older than those of stable couples, but also have systematically longer birth intervals compared with controls, see Table 2. A real mixed conundrum of the 2 pivotal competing and concurrent risk factors (paternity and interbirth intervals). However, in Table 3, using a multiple logistic regression model, all the adjusted odds-ratios giving the true weight of each item, demonstrating the major independent effect of a change in paternity.

That the PE risk may increase by parity, interbirth interval and advanced maternal age has been also clearly detected and written down by Tandberg et al. in 2013 [11], but they did not emphasize that the adjusted OR of these risks were clearly of a much lower magnitude compared with conditions such as chronic hypertension or history of PE. In our model, primipaternity clearly belongs to the cluster of major risks factors after controlling for ages, intervals, BMIs and parities. Intervals between pregnancies have a significant effect, p = 0.002, Table 3 with an adjOR of 1.05, a lower effect than successive pregnancies (adjOR 1.09), pre-pregnancy BMI (adjOR 1.05), but higher than advancing maternal age (adjOR 1.02). These four well-known risks represent a different cluster totally apart with major risk factors such as primigravidty, primipaternity, history of PE or chronic hypertension.

In explaining the the primipaternity paradigm, to date, two major hypotheses (which may be complementary) and are extensively developed in some recent paper [8,16]. Firstly, David Haig’s (check refencing) paternal maternal conflict in pregnancy [17] and secondly, the immunological challenge [18,19] which is also associated with the concept of a necessary long sperm exposure (paternal tissues) in first pregnancies results in a partner specific mucosal tolerance [20]. The haemochorial placenta in primates, and in particular in humans with the deepest invasion represents a scenario where the mother is facing a more or less human-specific major immune challenge, the “fetal hemi-allograft paradox” [19,21] first mentioned by Medawar, prior pregnancies in the same relationship translate in developed “trained immunological memory” in line with well-known epidemiologic findings of lower rates of PE, fetal growth restriction, fetal demise, and low birthweight in subsequent pregnancies. Moreover, we now appreciate that shallow endovascular trophoblast invasion is primarily linked to IUGR (with or without the maternal syndrome of preeclampsia) [22,23].

The strength of our study is, first, the capturing of all perinatal outcomes in our maternity, European standard of care. With 4,300 births per year, the university maternity, level 3, represents 82% of all births in the south of the island. but, as level 3 manages all cases of PE.The data in this large cohort are homogeneous as they were collected in a single center (lower variability) and not based on national birth registers but directly from medical records (avoiding inadequate codes). Second: Reunion island is an overseas department of France in the Indan ocean, and, as such, has the highest per capita gross domestic income of the area (e.g South-Africa, Mozambique, Madagascar, Mauritius island, Seychelles etc….). Furthermore, access to maternity care free of charge as provided by the French healthcare system which combines freedom of medical practice with social security. Hospitals have European standards of care and pregnant have an average of 8 prenatal visits and 4 ultrasounds during their pregnancy.Third, The specificity of our cohort with cultural and social and genetic backgrounds different than other already published studies made in different populations could yield different results. Reunion Island is a French department in the Southern Indian Ocean. The peculiarity of this tropical region lays in the multiethnic origin of inhabitants: Africa and intermixed population (50%), Europe (27%), India (20%) and China (3%). However, we feel this represents a strength of this particular study: this territory witnessed two centuries of slavery until 1848, where official marriages were forbidden for slaves by masters. These communities then reacted by reproducing often with different fathers in successive pregnancies. This scheme remains embedded in this society, where it is not a problem for women to say if a father is a new one or not (well-known pattern which has been described for 4–5 decades by demographers as “Women Family Structures” in the Caribbean’s or in American areas where slavery existed).

A weakness of this study is that primipaternity was obviously underestimated as this issue has been added in our database and then prospectively recorded only since 2018. Since then, we have approximately 190 multiparas per year having a new male partner (5.6% of our multiparas). New paternity was recalled during the period 2001–2017 on free commentaries possible in our database. These recalls based on free commentaries are then probably under-represented. We may assume that the retrieved free commentaries on paternity have been biased towards the risk of PE (as primipaternity is known to be associated with this disease [8]. However, we feel that this possible over-representation of preeclamptic pregnancies may be a “good bias” as, controlling for PE and birth intervals in multiparae, primipaternity remains a strong independent risk factor for PE, both for EOP but also for LOP).

Conclusion

Primipaternity is a markedly stronger risk for PE in multiparous women compared with the modest effect of prolonged birth intervals. Primipaternities in multiparae (immunological basis) belongs to the major risk factors for PE such as history of preeclampsia, chronic hypertension and multiple pregnancies while prolonged birth intervals belongs to moderate “regular physiological aging processes” such as increasing maternal age, parity or increasing pre-pregnancy BMI.

Supporting information

S1 Checklist. CHECK LIST PLOS: Fulfilling of the check list.

(DOCX)

pone.0312507.s001.docx (15.3KB, docx)
S1 File. CALCINTERV22: Calculations of results presented in Table 2.

BOMBINTERV Calculations for a Figure which has been removed from the final manuscript (after advices of reviewers. Figure shown in this file. EXPLORE INTERVALLESDOC: Calculations on maternal ages and BMI. INTERVAL: Calculations of results presented in Table 1. INTERVAL30: Preliminary results number of women by different parities 1-2-3etc….INTERVAL30B: Intervals between pregnancies by different parities 1-2-3etc…. comparisons between cases and controls presented also in Table 2. PRIMIPAT24: Complementary calculations of results presented in Table 1. LOGISTIC PAGE 1-2-3: Logistic regression results (Table 3).

(RAR)

pone.0312507.s002.rar (1.2MB, rar)

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med. 2002. Jan 3;346(1):33–8. doi: 10.1056/NEJMoa011379 . [DOI] [PubMed] [Google Scholar]
  • 2.Trogstad LI, Eskild A, Magnus P, Samuelsen SO, Nesheim BI. Changing paternity and time since last pregnancy; the impact on pre-eclampsia risk. A study of 547 238 women with and without previous pre-eclampsia. Int J Epidemiol. 2001. Dec;30(6):1317–22. doi: 10.1093/ije/30.6.1317 . [DOI] [PubMed] [Google Scholar]
  • 3.Trogstad L, Magnus P, Skjaerven R, Stoltenberg C: Previous abortions and risk of pre-eclampsia. Int J Epidemiology 2008; 37: 1333–1340. doi: 10.1093/ije/dyn167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Robillard PY, Hulsey TC, Alexander GR, Keenan A, de Caunes F, Papiernik E. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J Reprod Immunol. 1993. May;24(1):1–12. doi: 10.1016/0165-0378(93)90032-d . [DOI] [PubMed] [Google Scholar]
  • 5.Robillard PY, Hulsey TC, Périanin J, Janky E, Miri EH, Papiernik E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet. 1994. Oct 8;344(8928):973–5. doi: 10.1016/s0140-6736(94)91638-1 . [DOI] [PubMed] [Google Scholar]
  • 6.Dekker GA, Robillard PY, Hulsey TC. Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies. Obstet Gynecol Surv. 1998. Jun;53(6):377–82. doi: 10.1097/00006254-199806000-00023 . [DOI] [PubMed] [Google Scholar]
  • 7.Dekker GA, Robillard PY. Preeclampsia—an immune disease? An epidemiologic narrative. Explor Immunol. 2021;1:325–40. doi: 10.37349/ei.2021.00022 [DOI] [Google Scholar]
  • 8.Robillard PY, Dekker G, Scioscia M, Saito S. Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia. Am J Obstet Gynecol. 2022. Feb;226(2S):S867–S875. doi: 10.1016/j.ajog.2021.11.019 [DOI] [PubMed] [Google Scholar]
  • 9.Kho EM, McCowan LM, North RA, Roberts CT, Chan E, Black MA, Taylor RS, Dekker GA; SCOPE Consortium. Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. J Reprod Immunol. 2009. Oct;82(1):66–73. Epub 2009 Aug 12. doi: 10.1016/j.jri.2009.04.011 . [DOI] [PubMed] [Google Scholar]
  • 10.Tandberg A, Klungsøyr K, Romundstad LB, Skjærven R. Pre-eclampsia and assisted reproductive technologies: consequences of advanced maternal age, interbirth intervals, new partner and smoking habits. BJOG. 2015. Jun;122(7):915–22. Epub 2014 Aug 27. doi: 10.1111/1471-0528.13051 . [DOI] [PubMed] [Google Scholar]
  • 11.Li DK, Wi S. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am J Epidemiol. 2000. Jan 1;151(1):57–62. doi: 10.1093/oxfordjournals.aje.a010122 . [DOI] [PubMed] [Google Scholar]
  • 12.Hercus A, Dekker G, Leemaqz S. Primipaternity and birth interval; independent risk factors for preeclampsia. J Matern Fetal Neonatal Med. 2020. Jan;33(2):303–306. Epub 2018 Aug 13. doi: 10.1080/14767058.2018.1489794 . [DOI] [PubMed] [Google Scholar]
  • 13.Dekker G, Robillard PY. The birth interval hypothesis-does it really indicate the end of the primipaternity hypothesis. J Reprod Immunol. 2003. Aug;59(2):245–51. doi: 10.1016/s0165-0378(03)00051-2 . [DOI] [PubMed] [Google Scholar]
  • 14.WHO recommendations for prevention and treatment of preeclampsia and eclampsia. at:https://apps.who.int/iris/bitstream/handle/10665/119627/WHO_RHR_14.17_eng.pdf;jsessionid=2188B154C94951D203C9690998E73026?sequence=1, 2 February 2019.
  • 15.Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 2018. Jul;13:291–310. [DOI] [PubMed] [Google Scholar]
  • 16.Robillard PY, Dekker G, Chaouat G, Scioscia M, Boukerrou M. Primipaternities and human birthweights. J Reprod Immunol. 2021. Sep;147:103365. Epub 2021 Aug 20. doi: 10.1016/j.jri.2021.103365 . [DOI] [PubMed] [Google Scholar]
  • 17.Haig D. Genetic conflicts in human pregnancy. Q Rev Biol. 1993. Dec;68(4):495–532. doi: 10.1086/418300 . [DOI] [PubMed] [Google Scholar]
  • 18.Chaouat G. Inflammation, NK cells and implantation: friend and foe (the good, the bad and the ugly?): replacing placental viviparity in an evolutionary perspective. J Reprod Immunol. 2013. Mar;97(1):2–13. Epub 2013 Jan 22. doi: 10.1016/j.jri.2012.10.009 . [DOI] [PubMed] [Google Scholar]
  • 19.Goldman-Wohl D, Gamliel M, Mandelboim O, Yagel S. Learning from experience: cellular and molecular bases for improved outcome in subsequent pregnancies. Am J Obstet Gynecol. 2019. Sep;221(3):183–193. Epub 2019 Feb 22. doi: 10.1016/j.ajog.2019.02.037 . [DOI] [PubMed] [Google Scholar]
  • 20.Robillard PY, Dekker G, Chaouat G, Hulsey TC, Saftlas A. Epidemiological studies on primipaternity and immunology in preeclampsia—a statement after twelve years of workshops. J Reprod Immunol. 2011. May;89(2):104–17. Epub 2011 May 4. doi: 10.1016/j.jri.2011.02.003 . [DOI] [PubMed] [Google Scholar]
  • 21.Chavan AR, Griffith OW, Wagner GP. The inflammation paradox in the evolution of mammalian pregnancy: turning a foe into a friend. Curr Opin Genet Dev. 2017. Dec;47:24–32. Epub 2017 Aug 29. doi: 10.1016/j.gde.2017.08.004 . [DOI] [PubMed] [Google Scholar]
  • 22.Kho EM, McCowan LM, North RA, Roberts CT, Chan E, Black MA, Taylor RS, Dekker GA; SCOPE Consortium. Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. J Reprod Immunol. 2009. Oct;82(1):66–73. Epub 2009 Aug 12. doi: 10.1016/j.jri.2009.04.011 . [DOI] [PubMed] [Google Scholar]
  • 23.McCowan LM, North RA, Kho EM, Black MA, Chan EH, Dekker GA, Poston L, Taylor RS, Roberts CT. Paternal contribution to small for gestational age babies: a multicenter prospective study. Obesity (Silver Spring). 2011. May;19(5):1035–9. Epub 2010 Dec 2. doi: 10.1038/oby.2010.279 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Preenan Pillay

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

22 Jul 2024

PONE-D-24-23454RELATIVE INFLUENCE OF PRIMIPIPATERNITY AND PROLONGED BIRTH INTERVAL IN MULTIPARAE AS INDEPENDENT RISK FACTORS FOR PREECLAMPSIA;A STUDY OF 33.000 SINGLETON PREGNANCIES IN REUNION ISLANDPLOS ONE

Dear Dr. Robillard,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 05 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Preenan Pillay

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

Additional Editor Comments:

The following editorial comments must be addressed:

- Please revise the manuscript to meet the required formatting guidelines presented on our website. https://journals.plos.org/plosone/s/submission-guidelines

- The substance of the work is noted however the authors should refrain from discrediting other authors but rather scientifically contrast the different viewpoints of the argument. The entire manuscript needs to be rewritten to remove this as it presents an ethical non-conformance for PloS One. These types of comments are mainly evident in the introduction and conclusion of the manuscript. One example is as follows: (“The 2002 Skjaerven et al.'s statement: After adjustment for the interval birth, a change of partner is not associated with an increased risk of preeclampsia” severely disorientated the preeclampsia debate in a wrong direction during two decades.).

- The rationale and aim of the study must be rewritten with clarity and in an acceptable scientific format.

- The materials and methods must be written logically and scientifically in alignment with the work and claims made. Segmenting the methods will help in creating scientific flow which will enhance the readability. Importantly the study population size and design is not clear.

- The manuscript must be edited for English, neatness, syntax, grammar and ensure that it is written scientifically.

- The title must be revised to be more concise without being similar to other articles already published and aligned to the actual work done.

- It is suggested that the authors use statistical graphs where possible to clearly represent the results.

- The results section is inconsistent and needs to be rewritten. The results must be clearly specified which must be in alignment with the title and entire rationale of the study.

- The discussion must be revised for coherency and to critically discuss the key findings of the presented study.

- The authors should include a conflict of interest and discloser statement as per the Plos ethical guidelines and manuscript template

The following reviewer comments must be addressed:

Reviewer 1

Overall comments:

Positive Comments:

• Very detailed analysis and interpretation of results

• Novel study in term of cohort and factors studied.

• Large sample size provides more realistic picture of the risk factors

• Wealth of data to write other papers

• Study period of 24 years also gives credibility to the results showing changes over time

Areas to Address:

• The authors do not mention the specificity of the cohort having any bearing on the results. Other studies use different populations hence the disparity between results, different cultural and social and genetic backgrounds will yield different results.

• Study lacks theories or hypothesis as to why the results are such but rather authors explain the findings without explanation.

• Different font sizes and types show different sections written by different people but not carefully synthesized into one coherent paper.

Other specific comments per section:

Introduction

1. References are not consistent i.e. full stop after et al

2. Use of brackets after reference number [8,9] missing a closed bracket

MATERIAL AND METHODS.

3. Word missing...”at the maternity …” ward, department or unit?

4. Elaborate on how gestational hypertension and eclampsia were defined?

5. paragraph 5 after “Definition of exposure and outcomes”: ore-pregnancy should read pre-pregnancy

Results:

6. results need to be neatened up; data is scattered.

7. The narrative on page 15 for the figure has a duplication of the % sign

8. Check all figures containing decimals sone are represented as < 0..0001

Discussion

9. Discussion is very results and statistics-heavy heavy it needs more theory and explanation of the results

Reviewer 2

Comment #1: In the Abstract, Design and Main Outcome Measures should be restructured and described in more details related to PE risk factors, not only stated “… on obstetrical and neonatal risk factors” (?).

Comment #2: The objective of this study should be rephrased, clearly define the “problem” and without parentheses: “The aim of this study was to analyze the problem in our 24-year cohort in Reunion island using our detailed perinatal database where we have an item “changing paternity” by direct inquiry to the women (preeclamptic and controls).

Comment #3: The study period “from January 1st, 2001, to December 31, 2023” is 23 years.

Comment #4: In Results, tables and figures should be clearly formatted and figures with better resolution.

Comment #5: The authors stated “All relevant data are within the manuscript and its Supporting Information files”, but there is no additional data file available.

Comment #6: Excessive self-citation should be avoided and referencing the works from others are encouraged.

Comment #7: The manuscript should be checked carefully by a native for English spelling and grammar.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors reported the secondary analysis about the two risk-factors in question for development of peeclampsia (PE) among multipara pregnant women: (1) primipaternity, and (2) prolonged birth/pregnancy interval.

Despite its scientific merits, there are some flaws that should addressed, before re-submission for reconsideration.

Comment #1: In the Abstract, Design and Main Outcome Measures should be restructured and described in more details related to PE risk factors, not only stated “… on obstetrical and neonatal risk factors” (?).

Comment #2: The objective of this study should be rephrased, clearly define the “problem” and without parentheses: “The aim of this study was to analyze the problem in our 24-year cohort in Reunion island using our detailed perinatal database where we have an item “changing paternity” by direct inquiry to the women (preeclamptic and controls).

Comment #3: The study period “from January 1st, 2001, to December 31, 2023” is 23 years.

Comment #4: In Results, tables and figures should be clearly formatted and figures with better resolution.

Comment #5: The authors stated “All relevant data are within the manuscript and its Supporting Information files”, but there is no additional data file available.

Comment #6: Excessive self-citation should be avoided and referencing the works from others are encouraged.

Comment #7: The manuscript should be checked carefully by a native for English spelling and grammar.

Reviewer #2: 1. The Manuscript is technically sound, with rigorous statistical techniques and data availability.

2. The manuscript does need major revision for English, neatness, syntax and grammar.

3. major concern is the scarcity of linking results with physiological background and theory.

4. authors fail to hypothesize the rationale behind finding these results and the risk factors.

5. the niche population which could assist in explaining the results are not mentioned. e.g. is it a developing country with poor healthcare standards. lack of education hence seeking multiple fathers etc.

6. attachment uploaded with specific areas of improvement.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: plos one paper review comments.docx

pone.0312507.s003.docx (17.4KB, docx)
PLoS One. 2024 Dec 23;19(12):e0312507. doi: 10.1371/journal.pone.0312507.r002

Author response to Decision Letter 0


3 Aug 2024

REVIEWERS’ COMMENTS.

1. EDITOR COMMENTS. Answers in green in the text

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

We have added, page 6 : Ethics approval: This study was conducted in accordance with French legislation. As per new French law applicable to trials involving human subjects (Jardé Act), a specific approval of an ethics committee (comité de protection des personnes- CPP) is not required for this non-interventional study based on retrospective, anonymized data of authorized collections and written patient consent is not needed. Patients and Public involvement. The South-Reunion perinatal database (since 2001) includes 264 items. It is considered as a fully medical database , datasheets are electronically completed solely by midwives, obstetricians and neonatologists. All epidemiological studies are obligatorily performed on anonymized data (French law). As such, there is no direct patient or public involvement.

Additional Editor Comments:

The following editorial comments must be addressed:

- Please revise the manuscript to meet the required formatting guidelines presented on our website. https://journals.plos.org/plosone/s/submission-guidelines

- The substance of the work is noted however the authors should refrain from discrediting other authors but rather scientifically contrast the different viewpoints of the argument. The entire manuscript needs to be rewritten to remove this as it presents an ethical non-conformance for PloS One. These types of comments are mainly evident in the introduction and conclusion of the manuscript. One example is as follows: (“The 2002 Skjaerven et al.'s statement: After adjustment for the interval birth, a change of partner is not associated with an increased risk of preeclampsia” severely disorientated the preeclampsia debate in a wrong direction during two decades.).

We have re-written the INTRODUCTION, deleting 6 lines (essentially after new modification now in dark gree in the text). The modifications beginning at the 3rd paragraph. We have deleted the sentence « was published in the very prestigious NEJM ».

The new text now is :

« The Skjaerven et al.’s NEJM paper had a tremendous impact as it directly disagreed with our preceding publications on the importance of ‘primipaternity’ in 1993 and 1994 (the last one in The Lancet) [4,5]. In those studies we showed that in Guadeloupe (French West Indies) a change of paternity for the index pregnancy, based on direct inquiries with multiparas, was strongly associated with PE [5]. Over the past decades the relative importance of prolonged birth interval versus primipaternity has remained a controversial topic.. From an etiological perspective, this ongoing scientific debate is not a trivial one; evidently, the primipaternity paradigm is in line with the fundamental concept that human placentation may be considered as a “fetal hemigraft” , and as such the classic superficial cytotrophoblast invasion of the spiral particularly in early-onset PE with fetal growth restriction could therefore represent a type of immunological maladaptation of this fetal hemigraft [7-10]. On the other hand, prolonged interval between pregnancies in multiparas as a direct major risk factor for PE appears to be more in line with a kind of vascular maternal problem that increases progressively with time (a kind of “aging approach”). This was also supported by Tanberg et al. (also in Norway) who concluded on a cohort of 500,000 mothers after assisted reproductive technologies (ART, period 1988 to 2009 – so with a ten year overlap of the prior Skjaerven cohort) that the PE risk may increase by parity, interbirth interval and advanced maternal age, but with not with change of father or smoking [11]. In contrast, in 2000 a study published by Li and Wi based on 140,147 women with two consecutive births (Californian birth certificate 1989-1991) [12] among women without PE/eclampsia in the 1st pregnancy, changing partners resulted in a 30% increase in the risk in the subsequent pregnancy compared with those who did not change partner (95% CI: 1.1-1.6). On the other hand, among women with PE in the 1st birth, changing partner resulted in a 30% reduction in the risk of PE in the subsequent pregnancy (95% CI: 0.4- 1.2). Interbirth interval was very unlikely to be a confounder in the Li and Wi study since the authors restricted their population to births that were between 1-3 years apart [12]. Hercus and Dekker in an Australian population studied this problem in 2020 [13] and concluded that “both prolonged birth intervals and primipaternity are independent risk factors for preeclampsia in multigravidae”.

Notwithstanding the fact that we have previously discussed some concerns regarding the Skjaerven’s study [6-8], it is clear that the relative importance of prolonged birth interval versus primipaternity as PE risk factor in multiparous women still represents an important fundamental research question.

The aim of this study was to address this fundamental question by a comprehensive analysis of our 23year pregnancy cohort in Reunion island using a detailed high quality perinatal database where we have an item “changing paternity” by direct inquiry to the women (PE and controls).”

IN THE CONCLUSION we deleted the sentence

“The 2002 Skjaerven et al.'s statement: “After adjustment for the interval birth, a change of partner is not associated with an increased risk of preeclampsia” severely disorientated the preeclampsia debate in a wrong direction during two decades. »

- The rationale and aim of the study must be rewritten with clarity and in an acceptable scientific format.

In the abstract, we modified :

Objectives : To evaluate the relative importance of changing paternity (“primipaternity”) in multiparas versus prolonged birth/pregnancy interval as risk factors for preeclampsia (PE).

Main outcome Measures. The aim of this study was to analyze the problem in our population using our detailed perinatal database where we have an item “changing paternity” by direct inquiry to the women (preeclamptic and controls). Comparison of risk factors for PE between multiparae with a new male partner for the index pregnancy versus stable couples.

- The materials and methods must be written logically and scientifically in alignment with the work and claims made. Segmenting the methods will help in creating scientific flow which will enhance the readability. Importantly the study population size and design is not clear.

At the beginning of material and methods we added:

The aim of this study was to evaluate the relative importance of changing paternity (“primipaternity”) in multiparas versus prolonged birth/pregnancy interval as risk factors for preeclampsia (PE) using in our perinatal database the item “changing paternity” by direct inquiry to the women (preeclamptic and controls). Comparison of risk factors for PE between multiparae with a new male partner for the index pregnancy versus stable couples.

Page 5, we wrote :

Definition of exposure and outcomes . During the 23-year period all consecutive singleton pregnancies after 22 weeks gestation have been analysed. For multiparas, women who had changed the male partner for the index pregnancy were considered as cases, those who did not were the controls.

- The manuscript must be edited for English, neatness, syntax, grammar and ensure that it is written scientifically.

Professor Dekker verified entierly the text

- The title must be revised to be more concise without being similar to other articles already published and aligned to the actual work done.

THE NEW TITLE IS NOW :

PRIMIPATERNITY IN MULTIPARAS IS HIGHLY PREDOMINANT AS RISK FACTOR FOR PREECLAMPSIA OVER PROLONGED BIRTH INTERVALS. A STUDY OF 33.000 SINGLETON PREGNANCIES IN REUNION ISLAND

SHORT TITLE :

PREECLAMPSIA AND MULIPARAS: PRIMIPATERNITY IS A HIGHER RISK FACTOR THAN PROLONGED BIRTH INTERVALS

- It is suggested that the authors use statistical graphs where possible to clearly represent the results.

We feel that Figure 2 : Significant adjusted odds ratios of several risk factors for early (EOP) and late onset (LOP) preeclampsia.

Although unusual gives a visual direct impact for the real impact of the 2 risk factors studied (all results adjusted Odds-ratios)

- The results section is inconsistent and needs to be rewritten. The results must be clearly specified which must be in alignment with the title and entire rationale of the study.

We have made modifications (dark green in the text)

- The discussion must be revised for coherency and to critically discuss the key findings of the presented study.

We have modified a lot the discussion (through the 2 reviewers’ suggestion). We came also from 14 references to 23

- The authors should include a conflict of interest and discloser statement as per the Plos ethical guidelines and manuscript template

At the end of Material and methods we added : « Conflict of interest. The authors report no conflict of interest ».

The following reviewer comments must be addressed:

2. Reviewer 1. Answers in red in the text

Overall comments:

Positive Comments:

• Very detailed analysis and interpretation of results

• Novel study in term of cohort and factors studied.

• Large sample size provides more realistic picture of the risk factors

• Wealth of data to write other papers

• Study period of 24 years also gives credibility to the results showing changes over time

Areas to Address:

• The authors do not mention the specificity of the cohort having any bearing on the results. Other studies use different populations hence the disparity between results, different cultural and social and genetic backgrounds will yield different results.

We have added in strength and limitation, page 14 : « The specificity of our cohort with cultural and social and genetic backgrounds different than other already published studies made in different populations could yield different results. Reunion Island is a French department in the Southern Indian Ocean. The peculiarity of this tropical region lays in the multiethnic origin of inhabitants: Africa and intermixed population (50%), Europe (27%), India (20%) and China (3%). However, we feel it can be a strength for this particular study: this territory witnessed two centuries of slavery until 1848, where official marriages were forbidden for slaves by masters. These communities then reacted by reproduction being often with different fathers in successive pregnancies. This scheme remains embedded in this society, where it is not a problem for women to say if a father is a new one or not (well-known pattern which has been described for 4-5 decades by demographers as “Women Family Structures” in the Carribbeans or in American areas where slavery existed). “

• Study lacks theories or hypothesis as to why the results are such but rather authors explain the findings without explanation.

We have added, page 14 a long paragraph explaining the biological plausibility of the « primipaternity concept » : « What is the biologic explanation for the primipaternity paradigm ? To date, two major hypotheses (which may be complementary) and are extensively developed in some recent paper [8, 16]: First, David Haig’s paternal-maternal conflict in every pregnancy [17], second, the immunological one [18,19] also associated with the concept of a necessary long sperm exposure (paternal tissues) in first pregnancies results in a partner specific mucosal tolerance [20]. Immunology of reproduction has made giant leaps during the last two decades: The haemochorial placenta in primates, and in particular in humans with the deepest invasion represents a scenario where the mother is facing a more or less human-specific major immune challenge, the “fetal hemi-allograft paradox ” [19] first mentioned by Medawar, Prior pregnancies in the same relationship translate in developped ta “trained immunological memory” in line with well known epidemiologic findings of lower rates o f of PE , fetal growth restriction, fetal demise, and low birthweight in subsequent pregnancies. Also, we now appreciate that shallow endovascular trophoblast invasion is primarily linked to IUGR (with or without the maternal syndrome of preeclampsia) [22, 23].

• Different font sizes and types show different sections written by different people but not carefully synthesized into one coherent paper. Corrected

Other specific comments per section:

Introduction

1. References are not consistent i.e. full stop after et al. This reference has been deleted (critic on self-citation)

2. Use of brackets after reference number [8,9] missing a closed bracket

corrected

MATERIAL AND METHODS.

3. Word missing...”at the maternity …” ward, department or unit?

Corrected : department

4. Elaborate on how gestational hypertension and eclampsia were defined?

We have modified page 5 : ”Preeclampsia was defined according to the World Health Organization recommendations [14] and the International Society for the study of Hypertension in Pregnancy ) relatively to the guidelines in force at the year of pregnancy. [15] as the new onset of hypertension (BP ≥140 mmHg systolic or ≥90 mm Hg diastolic) at or after 20 weeks’ gestation and substantial proteinuria (> 0.3 g/24 hours). Early onset preeclampsia was defined as preeclampsia that developed before 34 weeks of gestation.”

5. paragraph 5 after “Definition of exposure and outcomes”: ore-pregnancy should read pre-pregnancy. Corrected

Results:

6. results need to be neatened up; data is scattered. We divided the results to be connected with the different Tables as it is recommended by PLOS (Tables embeded inside the text)

7. The narrative on page 15 for the figure has a duplication of the % sign. Corrected thank you

8. Check all figures containing decimals sone are represented as < 0..0001. Corrected thank you

9 Discussion. Discussion is very results and statistics-heavy heavy it needs more theory and explanation of the results. Paragraph added page 14, pleas see above

10. The authors stated “All relevant data are within the manuscript and its Supporting Information files”, but there is no additional data file available.

Reviewer 2. Answers in blue in the text

Comment #1: In the Abstract, Design and Main Outcome Measures should be restructured and described in more details related to PE risk factors, not only stated “… on obstetrical and neonatal risk factors” (?).

We have precised : « obstetrical and neonatal risk factors (156 items in total, of which, chronic or gestational hypertension, proteinuria, HELLP syndrome).”

Comment #2: The objective of this study should be rephrased, clearly define the “problem” and without parentheses: “The aim of this study was to analyze the problem in our 24-year cohort in Reunion island using our detailed perinatal database where we have an item “changing paternity” by direct inquiry to the women (preeclamptic and controls).

The sentence is now : »The aim of this study was to analyze the problem in our using our detailed perinatal database where we have an item “changing paternity” by direct inquiry to the women (preeclamptic and controls). Comparison of risk factors for PE between multiparae with a new male partner for the index pregnancy versus stable couples.”

Comment #3: The study period “from January 1st, 2001, to December 31, 2023” is 23 years. Corrected thank you

Comment #4: In Results, tables and figures should be clearly formatted and figures with better resolution.

Comment #5: The aut

Attachment

Submitted filename: Critics reviewers.docx

pone.0312507.s004.docx (29.6KB, docx)

Decision Letter 1

Preenan Pillay

12 Aug 2024

PONE-D-24-23454R1PRIMIPATERNITY IN MULTIPARAS IS HIGHLY PREDOMINANT AS RISK FACTOR FOR PREECLAMPSIA OVER PROLONGED BIRTH INTERVALS. A STUDY OF 33.000 SINGLETON PREGNANCIES IN REUNION ISLANDPLOS ONE

Dear Dr. Robillard,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Please kindly address all recommendations effectively and ensure that you follow all scientific standards in disseminating your findings.==============================

Please submit your revised manuscript by Sep 26 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Preenan Pillay

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Thank you for your revisions. We however believe that there are some minor revisions that need to be made before we consider your manuscript for publication. They are as follows:

Editorial Comments:

General:

- Inclusion of more scientific information in the methods section as indicated.

- Revision of statements for consistency and coherency

- Correct English and grammar

- Correct statements to a more scientific format

-Check refencing consistency according to PlOs One policies

Title suggestion:

Primipaternity in Multiparas as a Predominantly High Risk Factor for Preeclampsia Over prolonged birth intervals: A study of Singleton Pregnancies in Reunion Island

Abstract:

Segment Abstract according to the following sections

- Introduction

- Methods – Mention briefly the actual methods used. There is mention of assessment but not what the actual assessment is about.

- Results

- Conclusion and Relevance

Introduction:

I recommend that the authors change the following paragraphs:

Interestingly Trogstadt et al (with Skjaerven as one of the co-authors) looked at the effect of prior miscarriage/abortions (< 22 week’s gestation) in nulliparous women (Norwegian MoBa cohort) [3] and showed that prior abortion with the same partner reduced the risk for PE but not in women with new paternity pregnancies and the authors concluded that normal pregnancies interrupted at early gestation may induce immunological changes that reduce the risk of preeclampsia in a subsequent pregnancy.

The Skjaerven et al.’s NEJM paper had a tremendous impact as it directly disagreed with our preceding publications on the importance of ‘primipaternity’ in 1993 and 1994 (the last one in The Lancet) [4,5].

To:

Interestingly, Trogstadt et al. investigated the effect of prior miscarriage/abortions (< 22 week’s gestation) in nulliparous women within a Norwegian MoBa cohort [3]. This study identified that prior to abortion with the same partner a reduced risk of PE was observed however, not in women with new paternity pregnancies. These findings suggested that normal pregnancies interrupted at early gestation may induce immunological changes that reduce the risk of preeclampsia in subsequent pregnancies.

Importantly, a study by Skjaerven et al.’s [add reference] had tremendous impact as it directly contrasted our preceding publications on the importance of ‘primipaternity’ [4,5].

Methods:

Add more details on the following methods and parameters applied per the software package used since multiple software platforms were used:

‘Epidemiological data have been recorded and analysed with the software EPI-INFO 7.1.5 (2008, CDC Atlanta, OMS), EPIDATA 3.0 and EPIDATA Analysis V2.2.2.183. Denmar’

I suggest specifying the package used for each statistical test done and also adding more detail on the other tests done using the software.

Results:

- Intext references to tables and figures should be included and must be consistent.

- Authors must adjust figure to a 2D format the 3D format is not for scientific publication as a publication must be as clear as possible to read.

- Authors must not use bullets to disseminate their findings and must write their findings in a clear scientific manner for coherency, the bullet points are okay for power point presentations but not for publication purposes.

Discussion

- Authors must not use bullets to discuss their work and must write their findings in a clear scientific manner for coherency, the bullet points are okay for power point presentations but not for publication purposes.

- I recommend the authors change the following paragraph:

What is the biologic explanation for the primipaternity paradigm ? To date, two major hypotheses (which may be complementary) and are extensively developed in some recent paper [8, 16]: First, David Haig’s paternal maternal conflict in every pregnancy [17], second, the immunological one [18,19] also associated with the concept of a necessary long sperm exposure (paternal tissues) in first pregnancies results in a partner specific mucosal tolerance [20]. Immunology of reproduction has made giant leaps during the last two decades: The haemochorial placenta in primates, and in particular in humans with the deepest invasion represents a scenario where the mother is facing a more or less human-specific major immune challenge, the “fetal hemi-allograft paradox ” [19] first mentioned by Medawar, Prior pregnancies in the same relationship translate in developped ta “trained immunological memory” in line with well known epidemiologic findings of lower rates o f of PE , fetal growth restriction, fetal demise, and low birthweight in subsequent pregnancies. Also, we now appreciate that shallow endovascular trophoblast invasion is primarily linked to IUGR (with or without the maternal syndrome of preeclampsia) [22, 23]

TO

In explaining the the primipaternity paradigm, to date, two major hypotheses (which may be complementary) and are extensively developed in some recent paper [8, 16]. Firstly, David Haig’s (check refencing) paternal maternal conflict in pregnancy [17] and secondly, the immunological challenge [18,19] which is also associated with the concept of a necessary long sperm exposure (paternal tissues) in first pregnancies results in a partner specific mucosal tolerance [20]. The haemochorial placenta in primates, and in particular in humans with the deepest invasion represents a scenario where the mother is facing a more or less human-specific major immune challenge, the “fetal hemi-allograft paradox ” [19] first mentioned by Medawar, prior pregnancies in the same relationship translate in developed “trained immunological memory” in line with well-known epidemiologic findings of lower rates of PE , fetal growth restriction, fetal demise, and low birthweight in subsequent pregnancies. Moreover, we now appreciate that shallow endovascular trophoblast invasion is primarily linked to IUGR (with or without the maternal syndrome of preeclampsia) [22, 23]

- Remove etc from the following sentence and change further to furthermore: (e.g South-Africa, Mozambique, Madagascar, Mauritius island, Seychelles etc….). Further,

Reviewer Recommendations:

Comment #1: At the end of Materials & methods, there is the section “Fundings: The author(s) received no specific funding for this work. Conflict of interest. The authors report no conflict of interest”, this should be removed and inserted at the appropriate position.

Comment #2: In Results, tables and figures should be clearly formatted and figures with better resolution

Comment #3: Many punctuation errors should be corrected.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: PONE-D-24-23454R1

RELATIVE INFLUENCE OF PRIMIPIPATERNITY AND PROLONGED BIRTH INTERVAL INMULTIPARAE AS INDEPENDENT RISK FACTORS FOR PREECLAMPSIA;A STUDY OF 33.000 SINGLETON PREGNANCIES IN REUNION ISLAND

changed into

PRIMIPATERNITY IN MULTIPARAS IS HIGHLY PREDOMINANT AS RISK FACTOR FOR PREECLAMPSIA OVER PROLONGED BIRTH INTERVALS. A STUDY OF 33.000 SINGLETON PREGNANCIES IN REUNION ISLAND

Most of comments and suggestions raised within the original manuscript have been solved in the revised version R1. The manuscript needs some minor revisions before being considered for publication.

Comment #1: At the end of Materials & methods, there is the section “Fundings: The author(s) received no specific funding for this work. Conflict of interest. The authors report no conflict of interest”, this should be removed and inserted at the appropriate position.

Comment #2: In Results, tables and figures should be clearly formatted and figures with better resolution

Comment #3: Many punctuation errors should be corrected.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Dec 23;19(12):e0312507. doi: 10.1371/journal.pone.0312507.r004

Author response to Decision Letter 1


20 Aug 2024

1. Journal requirements

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

We have verified the references which are in the format such as :

Kho EM, McCowan LM, North RA, Roberts CT, Chan E, Black MA, Taylor RS, Dekker GA; SCOPE Consortium. Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. J Reprod Immunol. 2009 Oct;82(1):66-73. doi: 10.1016/j.jri.2009.04.011. Epub 2009 Aug 12. PMID: 19679359.

2. Editorial Comments: ANSWER IN DARK GREEN IN THE TEXT

Additional Editor Comments:

Thank you for your revisions. We however believe that there are some minor revisions that need to be made before we consider your manuscript for publication. They are as follows:

Thank you for these very postive critics which improve the quality f the text. WE HAVE REMOVED FIGURE 1 WHICH ALSO AS YOU SAY « are okay for power point presentations but not for publication purposes. ». Therefore, former Figure 2 becomes Figure 1

General:

- Inclusion of more scientific information in the methods section as indicated.

- Revision of statements for consistency and coherency

- Correct English and grammar

- Correct statements to a more scientific format

-Check refencing consistency according to PlOs One policies

Title suggestion:

Primipaternity in Multiparas as a Predominantly High Risk Factor for Preeclampsia Over prolonged birth intervals: A study of Singleton Pregnancies in Reunion Island

The new title is now (as also sggested by reviewer 1) is :

PRIMIPATERNITY IN MULTIPARAS AS A PREDOMINANT HIGH RISK FACTOR FOR PREECLAMPSIA OVER PROLONGED BIRTH INTERVALS : A STUDY OF 33,000 SINGLETON PREGNANCIES IN REUNION ISLAND

Abstract:

Segment Abstract according to the following sections

- Introduction

- Methods – Mention briefly the actual methods used. There is mention of assessment but not what the actual assessment is about.

We have modified :

Objectives : To evaluate the relative importance of changing paternity (“primipaternity”, direct inquiry with patients) in multiparas versus prolonged birth/pregnancy interval as risk factors for preeclampsia (PE) by a logistic regression model comparing the adjusted odds ratios of both exposures.

- Results

- Conclusion and Relevance

Conclusions. Primipaternities in multiparae belongs to the major risk factors such as history of preeclampsia, chronic hypertension, multiple pregnancies while prolonged birth intervals belongs to moderate “physiological or aging influence” such as increasing maternal age, parity or increasing pre-pregnancy BMI.

Introduction:

I recommend that the authors change the following paragraphs:

Interestingly Trogstadt et al (with Skjaerven as one of the co-authors) looked at the effect of prior miscarriage/abortions (< 22 week’s gestation) in nulliparous women (Norwegian MoBa cohort) [3] and showed that prior abortion with the same partner reduced the risk for PE but not in women with new paternity pregnancies and the authors concluded that normal pregnancies interrupted at early gestation may induce immunological changes that reduce the risk of preeclampsia in a subsequent pregnancy.

The Skjaerven et al.’s NEJM paper had a tremendous impact as it directly disagreed with our preceding publications on the importance of ‘primipaternity’ in 1993 and 1994 (the last one in The Lancet) [4,5].

To:

Interestingly, Trogstadt et al. investigated the effect of prior miscarriage/abortions (< 22 week’s gestation) in nulliparous women within a Norwegian MoBa cohort [3]. This study identified that prior to abortion with the same partner a reduced risk of PE was observed however, not in women with new paternity pregnancies. These findings suggested that normal pregnancies interrupted at early gestation may induce immunological changes that reduce the risk of preeclampsia in subsequent pregnancies.

Importantly, a study by Skjaerven et al.’s [add reference] had tremendous impact as it directly contrasted our preceding publications on the importance of ‘primipaternity’ [4,5].

NEW TEXTMODIFIED : Interestingly, Trogstadt et al. investigated the effect of prior miscarriage/abortions (< 22 week’s gestation) in nulliparous women within a Norwegian MoBa cohort [3]. This study identified that prior to abortion with the same partner a reduced risk of PE was observed however, not in women with new paternity pregnancies. These findings suggested that normal pregnancies interrupted at early gestation may induce immunological changes that reduce the risk of preeclampsia in subsequent pregnancies. Importantly, a study by Skjaerven et al.’s [1] had tremendous impact as it directly contrasted our preceding publications on the importance of ‘primipaternity’ [4,5].

Methods:

Add more details on the following methods and parameters applied per the software package used since multiple software platforms were used:

‘Epidemiological data have been recorded and analysed with the software EPI-INFO 7.1.5 (2008, CDC Atlanta, OMS), EPIDATA 3.0 and EPIDATA Analysis V2.2.2.183. Denmar’

We have added : .EPIDATA allowing the adaptation for WINDOWS 10 of the former EPI-INFO (MS DOS) in complete cooperation with CDC Atlanta. All calculations were made then with and EPIDATA Analysis V2.2.2.183. Denmark.

I suggest specifying the package used for each statistical test done and also adding more detail on the other tests done using the software.

All calculations were made then with and EPIDATA Analysis V2.2.2.183. Denmark.

Results:

- Intext references to tables and figures should be included and must be consistent. DONE

- Authors must adjust figure to a 2D format the 3D format is not for scientific publication as a publication must be as clear as possible to read.

FIGURE 1 (FORMER FIGURE 2) IS NOW IN 2D FORMAT

- Authors must not use bullets to disseminate their findings and must write their findings in a clear scientific manner for coherency, the bullet points are okay for power point presentations but not for publication purposes.

WE HAVE DELETED THE BULLETS AS WELL IN THE RESULTS AS IN THE DISCUSSION

Discussion

- Authors must not use bullets to discuss their work and must write their findings in a clear scientific manner for coherency, the bullet points are okay for power point presentations but not for publication purposes.

WE HAVE DELETED THE BULLETS AS WELL IN THE RESULTS AS IN THE DISCUSSION

- I recommend the authors change the following paragraph:

What is the biologic explanation for the primipaternity paradigm ? To date, two major hypotheses (which may be complementary) and are extensively developed in some recent paper [8, 16]: First, David Haig’s paternal maternal conflict in every pregnancy [17], second, the immunological one [18,19] also associated with the concept of a necessary long sperm exposure (paternal tissues) in first pregnancies results in a partner specific mucosal tolerance [20]. Immunology of reproduction has made giant leaps during the last two decades: The haemochorial placenta in primates, and in particular in humans with the deepest invasion represents a scenario where the mother is facing a more or less human-specific major immune challenge, the “fetal hemi-allograft paradox ” [19] first mentioned by Medawar, Prior pregnancies in the same relationship translate in developped ta “trained immunological memory” in line with well known epidemiologic findings of lower rates o f of PE , fetal growth restriction, fetal demise, and low birthweight in subsequent pregnancies. Also, we now appreciate that shallow endovascular trophoblast invasion is primarily linked to IUGR (with or without the maternal syndrome of preeclampsia) [22, 23]

TO

In explaining the the primipaternity paradigm, to date, two major hypotheses (which may be complementary) and are extensively developed in some recent paper [8, 16]. Firstly, David Haig’s (check refencing) paternal maternal conflict in pregnancy [17] and secondly, the immunological challenge [18,19] which is also associated with the concept of a necessary long sperm exposure (paternal tissues) in first pregnancies results in a partner specific mucosal tolerance [20]. The haemochorial placenta in primates, and in particular in humans with the deepest invasion represents a scenario where the mother is facing a more or less human-specific major immune challenge, the “fetal hemi-allograft paradox ” [19] first mentioned by Medawar, prior pregnancies in the same relationship translate in developed “trained immunological memory” in line with well-known epidemiologic findings of lower rates of PE , fetal growth restriction, fetal demise, and low birthweight in subsequent pregnancies. Moreover, we now appreciate that shallow endovascular trophoblast invasion is primarily linked to IUGR (with or without the maternal syndrome of preeclampsia) [22, 23]

THE NEW PARAGRAPH IS NOW :

In explaining the the primipaternity paradigm, to date, two major hypotheses (which may be complementary) and are extensively developed in some recent paper [8, 16]. Firstly, David Haig’s (check refencing) paternal maternal conflict in pregnancy [17] and secondly, the immunological challenge [18,19] which is also associated with the concept of a necessary long sperm exposure (paternal tissues) in first pregnancies results in a partner specific mucosal tolerance [20]. The haemochorial placenta in primates, and in particular in humans with the deepest invasion represents a scenario where the mother is facing a more or less human-specific major immune challenge, the “fetal hemi-allograft paradox ” [19] first mentioned by Medawar, prior pregnancies in the same relationship translate in developed “trained immunological memory” in line with well-known epidemiologic findings of lower rates of PE , fetal growth restriction, fetal demise, and low birthweight in subsequent pregnancies. Moreover, we now appreciate that shallow endovascular trophoblast invasion is primarily linked to IUGR (with or without the maternal syndrome of preeclampsia) [22, 23]

- Remove etc from the following sentence and change further to furthermore: (e.g South-Africa, Mozambique, Madagascar, Mauritius island, Seychelles etc….). Further,

DONE: Furthermore

3. Reviewer Recommendations: ANSWERS IN RED IN THE TEXT

Comment #1: At the end of Materials & methods, there is the section “Fundings: The author(s) received no specific funding for this work. Conflict of interest. The authors report no conflict of interest”, this should be removed and inserted at the appropriate position.

These have been put in final disclosure

Comment #2: In Results, tables and figures should be clearly formatted and figures with better resolution

Comment #3: Many punctuation errors should be corrected. Done

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

4. Have the authors made all data underlying the findings in their manuscript fully available?

Reviewer #1: Yes

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No Professor Dekker revised the English language

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: PONE-D-24-23454R1

RELATIVE INFLUENCE OF PRIMIPIPATERNITY AND PROLONGED BIRTH INTERVAL INMULTIPARAE AS INDEPENDENT RISK FACTORS FOR PREECLAMPSIA;A STUDY OF 33.000 SINGLETON PREGNANCIES IN REUNION ISLAND

changed into

PRIMIPATERNITY IN MULTIPARAS IS HIGHLY PREDOMINANT AS RISK FACTOR FOR PREECLAMPSIA OVER PROLONGED BIRTH INTERVALS. A STUDY OF 33.000 SINGLETON PREGNANCIES IN REUNION ISLAND

The new title (as suggested also by the Editor) is :

PRIMIPATERNITY IN MULTIPARAS AS A PREDOMINANT HIGH RISK FACTOR FOR PREECLAMPSIA OVER PROLONGED BIRTH INTERVALS : A STUDY OF 33,000 SINGLETON PREGNANCIES IN REUNION ISLAND

Most of comments and suggestions raised within the original manuscript have been solved in the revised version R1. The manuscript needs some minor revisions before being considered for publication.

Comment #1: At the end of Materials & methods, there is the section “Fundings: The author(s) received no specific funding for this work. Conflict of interest. The authors report no conflict of interest”, this should be removed and inserted at the appropriate position.

These have been put in final disclosure

Comment #2: In Results, tables and figures should be clearly formatted and figures with better resolution

Figure 1 (former Figure 2) has been reformatted .

Former Figure 1 has been removed

Attachment

Submitted filename: CRITICS REVISION 2 Plos one.docx

pone.0312507.s005.docx (31.6KB, docx)

Decision Letter 2

Preenan Pillay

28 Aug 2024

PRIMIPATERNITY IN MULTIPARAS AS A PREDOMINANT HIGH RISK FACTOR FOR PREECLAMPSIA OVER PROLONGED BIRTH INTERVALS : A STUDY OF 33,000 SINGLETON PREGNANCIES IN REUNION ISLAND

PONE-D-24-23454R2

Dear Dr. Robillard,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Preenan Pillay

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Good day,

Thank you for your revision.

I recommend the submitted manuscript be accepted for publication with the following compulsory amendments:

- Formatting

- English language editing including grammar checks.

- The graphs should not be in 3D and must conform to the graphing standards of PloS One.

- The tables must be formatted to the requirements of PloS One.

- A graphical abstract is recommended but not compulsory.

It is recommended that you kindly conduct these changes in accordance with the PloS one publication guidelines.

Kind Regards

Acceptance letter

Preenan Pillay

18 Oct 2024

PONE-D-24-23454R2

PLOS ONE

Dear Dr. Robillard,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof Preenan Pillay

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. CHECK LIST PLOS: Fulfilling of the check list.

    (DOCX)

    pone.0312507.s001.docx (15.3KB, docx)
    S1 File. CALCINTERV22: Calculations of results presented in Table 2.

    BOMBINTERV Calculations for a Figure which has been removed from the final manuscript (after advices of reviewers. Figure shown in this file. EXPLORE INTERVALLESDOC: Calculations on maternal ages and BMI. INTERVAL: Calculations of results presented in Table 1. INTERVAL30: Preliminary results number of women by different parities 1-2-3etc….INTERVAL30B: Intervals between pregnancies by different parities 1-2-3etc…. comparisons between cases and controls presented also in Table 2. PRIMIPAT24: Complementary calculations of results presented in Table 1. LOGISTIC PAGE 1-2-3: Logistic regression results (Table 3).

    (RAR)

    pone.0312507.s002.rar (1.2MB, rar)
    Attachment

    Submitted filename: plos one paper review comments.docx

    pone.0312507.s003.docx (17.4KB, docx)
    Attachment

    Submitted filename: Critics reviewers.docx

    pone.0312507.s004.docx (29.6KB, docx)
    Attachment

    Submitted filename: CRITICS REVISION 2 Plos one.docx

    pone.0312507.s005.docx (31.6KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES